Marshall Wace
VIVE

Marshall Wace’s VIVEVE MED INC VIVE Stock Holding History

Marshall Wace’s Portfolio VIVE Stock Details VIVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-441
Closed -$1.2M – 1316
2018
Q2 		$1.2M Buy
441
+44
+11% +$127K 0.02% 488
2018
Q1 		$1.46M Buy
+397
New +$1.73M 0.06% 234

Other funds holding VIVE

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace's VIVE Position: Q3 2018 in Review

Marshall Wace sold out of VIVEVE MED INC (VIVE) in Q3 2018, closing a stake of 441 shares — an estimated $1.2M sold.

Marshall Wace first reported a position in VIVE in Q1 2018 and held it in 2 quarters. The position peaked at $1.46M in Q1 2018. 36 funds tracked by Wall St. Rank hold VIVE as of Q3 2018.

  • Marshall Wace reported no remaining VIVEVE MED INC position as of Q3 2018 after selling out during the quarter.
  • Marshall Wace sold 441 VIVEVE MED INC shares in Q3 2018, an estimated $1.2M.
  • Marshall Wace first reported a position in VIVEVE MED INC in Q1 2018 and held it in 2 quarters.
  • Marshall Wace's VIVEVE MED INC position peaked at $1.46M in Q1 2018.
  • 36 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q3 2018.

Based on Marshall Wace's 13F filing for Q3 2018, filed 14 Nov 2018.